We are only able to display limited information for this firm. We display more complete information for all of the following firms:
Goldfarb Gross Seligman & Co. has broad exposure to the life sciences and healthcare industry, having maintained a key role in large M&A transactions, among them a $671m going private transaction for a major pharmaceutical company, as well as handling complex regulatory and licensing matters. Head of life sciences Hili Cohen is a key adviser to technology-based companies in the life sciences, medical devices, pharmaceuticals, digital health, telemedicine, diagnostics, and medical cannabis sectors. Corporate and commercial partner Danny Kleinhendler, emerging talent Shir Shalev, and Ofir Goldstein, who handles technology licensing agreements, investments, capital, and development agreements, are the standout practitioners in a diverse, multidisciplinary team.
Legal 500 Editorial commentary
Key clients
- 3 Millenium Group
- Abbott Laboratories
Work highlights
Representing medical device company Magenta Medical in its USD105m Series E financing round.
Representing the Special Committee of the Board of Directors of Taro Pharmaceutical Industries Ltd. in its USD671m going private transaction by merger with its controlling shareholder, SUN PHARMA Pharmaceutical Industries Limited.